21 CFR 524.1146
§ 524.1146 Imidacloprid and moxidectin.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 524.1146, § 524.1146 Imidacloprid and moxidectin, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/87614
- Permanent ID
ys:prov:87614@1- SHA-256
78ab338c7b6681a328030cfbe72219a02059e8cd4814abc9391cf1658c34387a
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) Specifications. Each milliliter of solution contains:
(1) 100 milligrams (mg) imidacloprid and 25 mg moxidectin; or
(2) 100 mg imidacloprid and 10 mg moxidectin.
(b) Sponsors. See sponsor numbers in § 510.600(c) of this chapter as follows:
(1) Nos. 017030, 051072, 051311, 055529, 058198, and 061133for use of product described in paragraph (a)(1) of this section as in paragraph (d)(1) of this section.
(2) Nos. 017030, 051072, 051311, 055529, 058198, and 061133 for use of product described in paragraph (a)(2) of this section as in paragraph (d)(2) of this section.
(3) Nos. 051072, 055529, 058198, 061133, and 061651 for use of product described in paragraph (a)(2) of this section as in paragraph (d)(3) of this section.
(c) Special considerations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
(d) Conditions of use—(1) Dogs—(i) Amount. Topically apply 4.5 mg/lb body weight (10 mg/kg) imidacloprid and 1.1 mg/lb (2.5 mg/kg) moxidectin, once a month.
(ii) Indications for use.
(A) For the prevention of heartworm disease caused by Dirofilaria immitis; and the treatment and control of intestinal roundworms (Toxocara canis and Toxascaris leonina), hookworms (Ancylostoma caninum and Uncinaria stenocephala), and whipworms (Trichuris vulpis); kills adult fleas and treats flea infestations (Ctenocephalides felis).
(B) For treatment of Dirofilaria immitis circulating microfilariae in heartworm-positive dogs and the treatment and control of sarcoptic mange caused by Sarcoptes scabiei var. canis.
(2) Cats—(i) Amount. Topically apply 4.5 mg/lb body weight (10 mg/kg) imidacloprid and 0.45 mg/lb (1.0 mg/kg) moxidectin, once a month.
(ii) Indications for use. For the prevention of heartworm disease caused by Dirofilaria immitis; for the treatment and control of ear mite (Otodectes cynotis) infestations, intestinal roundworms (Toxocara cati), and hookworms (Ancylostoma tubaeforme); kills adult fleas and treats flea infestations (Ctenocephalides felis).
(3) Ferrets—(i) Amount. Topically apply 9.0 mg/lb body weight (20 mg/kg) imidacloprid and 0.9 mg/lb (2 mg/kg) moxidectin, once a month.
(ii) Indications for use. For the prevention of heartworm disease caused by Dirofilaria immitis; kills adult fleas (Ctenocephalides felis) and is indicated for the treatment of flea infestations on ferrets.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.